Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
307 participants
INTERVENTIONAL
2016-03-24
2019-12-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Connecting National Guard Service Members Through Education in Crisis Line Facilitation Training
NCT05405231
Increasing Treatment Seeking Among Suicidal Veterans Calling the Crisis Line
NCT01771965
Assessing the Effectiveness of Self- and Clinician-administered Crisis Response Planning for Suicide Risk
NCT04903431
Brief Interventions for Short-Term Suicide Risk Reduction in Military Populations
NCT02042131
Crisis Response Planning for Military Personnel
NCT05795764
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Crisis Line Facilitation (CLF)
Crisis Line Facilitation
Crisis Line Facilitation (CLF)
This single session therapist-delivered intervention addresses Veterans' perceived barriers and facilitators of crisis line use during periods of suicidal crisis. The CLF session culminates with the Veteran calling the Crisis Line with the therapist in the room as a way for the Veteran to practice the logistics of making the call and to have direct experiences that may counter any negative beliefs about Crisis Line use.
Enhanced Usual Care (EUC)
Enhanced Usual Care
Enhanced Usual Care (EUC)
Those in the EUC condition received the same promotional items and information about the Veterans Crisis Line (VCL) as the CLF condition. Participants were encouraged to seek help via a provider or the VCL if they felt suicidal in the future. Research staff briefly explained key information about the VCL to those in the EUC condition (e.g., the links between the VCL and the VA, the 24/7/365 availability, etc.).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Crisis Line Facilitation (CLF)
This single session therapist-delivered intervention addresses Veterans' perceived barriers and facilitators of crisis line use during periods of suicidal crisis. The CLF session culminates with the Veteran calling the Crisis Line with the therapist in the room as a way for the Veteran to practice the logistics of making the call and to have direct experiences that may counter any negative beliefs about Crisis Line use.
Enhanced Usual Care (EUC)
Those in the EUC condition received the same promotional items and information about the Veterans Crisis Line (VCL) as the CLF condition. Participants were encouraged to seek help via a provider or the VCL if they felt suicidal in the future. Research staff briefly explained key information about the VCL to those in the EUC condition (e.g., the links between the VCL and the VA, the 24/7/365 availability, etc.).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* mention of a significant suicidal crisis within the intake note;
* medically stable and able to provide informed consent; and
* Mini-Mental State Examination (MMSE) score greater than or equal to 21.
* no reported use of the Veterans Crisis Line within the past 12-months;
* report current suicidal ideation (BSS greater than or equals 5 during the week prior to hospitalization) as reported during the screening interview.
Exclusion Criteria
* prisoners;
* patients deemed unable to provide informed consent as stated above;
* patients who recently received or are scheduled to receive electroconvulsive therapy (ECT); and
* profound psychotic symptoms and/or cognitive deficits that would prevent patients from understanding the content of the intervention and/or assessments.
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VA Office of Research and Development
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mark A. Ilgen, PhD
Role: PRINCIPAL_INVESTIGATOR
VA Ann Arbor Healthcare System, Ann Arbor, MI
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VA Ann Arbor Healthcare System, Ann Arbor, MI
Ann Arbor, Michigan, United States
Battle Creek VA Medical Center, Battle Creek, MI
Battle Creek, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan: Ann Arbor
Document Type: Study Protocol and Statistical Analysis Plan: Battle Creek
Document Type: Informed Consent Form: Main Study Consent
Document Type: Informed Consent Form: Qualitative Interview Consents
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IIR 14-103
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.